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Langerhans Cells Are Not Required for Efficient Skin
Graft Rejection
Jagdeep S. Obhrai1,9, Martin Oberbarnscheidt1,9, Na Zhang2, Daniel L. Mueller2, Warren D. Shlomchik3,4,
Fadi G. Lakkis5,6, Mark J. Shlomchik4,7 and Daniel H. Kaplan8
The mechanism of skin allograft rejection has been thought to require presentation of graft antigen by resident
epidermal Langerhans cells (LCs). We have previously engineered mice that have a selective and constitutive
absence of epidermal LCs. By using donor skin from these LC-deficient mice, we show that LCs are not required
for rejection of major (FVB-B6) or minor (H-Y, male-female on B6 background) antigen-mismatched skin
grafts. On the FVB background, where H-Y mismatched grafts are normally maintained indefinitely, grafts
lacking LCs are efficiently rejected. Thus, LCs in the donor graft are required for long-term skin engraftment,
which supports a regulatory role for LCs in skin graft acceptance.
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INTRODUCTION
The current understanding of solid-tissue graft rejection holds
that graft antigens are presented to T cells by antigen-presenting
cells (APCs) in secondary lymphoid tissues (Rosenberg and
Singer, 1992; Lakkis et al., 2000). Dendritic cells (DCs) are
professional APCs that are central for many adaptive immune
responses (Banchereau et al., 2000). DCs of donor origin
present in the graft at the time of transplantation migrate to
regional lymph nodes and are thought to be important for
antigraft T-cell priming (Lechler et al., 2001). However, host
DCs that acquire graft antigens also participate in rejection, and
the relative contribution of donor and host-derived DCs is
unclear (Benichou et al., 1999; Chen et al., 2003; Reed et al.,
2003). In addition, there are many subtypes of DCs that differ in
location, marker expression, and function (Banchereau et al.,
2000). Certain subtypes, such as plasmacytoid DCs and DCs,
that have been exposed to IL-10 or tissue growth factor-b can
promote regulatory responses (Ochando et al., 2006; Svensson
and Kaye, 2006). The identity and characterization of the DC
subtype(s) that participate in rejection of graft tissue are critical
to understanding the mechanism and may provide targets for
novel therapeutic intervention.
In skin, the major DC subpopulation are Langerhans cells
(LCs), which reside in a dense network throughout the
epidermis (Romani et al., 2003). It has been long presumed
that donor LCs present in skin grafts migrate to regional
lymph nodes where they stimulate antigraft T-cell responses.
This is based on the observations that LCs migrate out of skin
grafts and that intact lymphatic connections to grafted skin
are required for rejection (Barker and Billingham, 1968;
Larsen et al., 1990). In addition, the observation that skin
grafts are more immunogenic than other solid organs, such as
heart, has been attributed to the large number of LCs serving
as professional APCs in the skin (He et al., 2004). Moreover,
the degree of immunogenicity of skin from different anatomic
locations correlated with the density of LCs (Mathieson et al.,
1975; Sena et al., 1976; Chen and Silvers, 1983). Although
LCs are the most numerous DC subtype in the skin, the data
supporting their role in graft rejection are correlative and
have not been formally demonstrated. There are other APCs
in the skin, including dermal DCs, macrophages, and host
DC, that are recruited during inflammation, all of which
could participate in graft rejection (Romani et al., 2003;
Larregina and Falo, 2005; Le Borgne et al., 2006).
We have recently generated bacterial artificial chromo-
some (BAC) transgenic mice that use the genomic locus
containing the LC-specific gene, Langerin, to selectively
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express diphtheria toxin subunit A (DTA) in LCs (Kaplan et al.,
2005). These Langerin-DTA mice have a constitutive and
complete absence of LCs in the epidermis, but other DCs in
the skin and secondary lymphoid tissues are unaffected.
Contact hypersensitivity (CHS) to cutaneously applied hap-
tens, the classic assay for adaptive skin immune responses,
was enhanced by approximately twofold in the absence of
LCs. This showed that LCs are not required and that they in
fact downregulate CHS responses.
To examine the requirement of LCs in skin graft rejection
directly, Langerin-DTA mice were used as skin donors in a
series of skin graft experiments.
RESULTS AND DISCUSSION
LCs are not required for major or minor antigen-mismatched
graft rejection
To investigate the requirement for LCs in skin graft rejection, we
focused first on a fully allogeneic skin transplant model. Partial
thickness skin was harvested from the flanks of Langerin-DTA
(Tgþ ) and littermate controls (wt), which were generated and
maintained on a pure FVB (H-2q) genetic background. Except
for the absence of LCs, wt and Tgþ partial thickness grafts are
histologically virtually indistinguishable and both contain
similar numbers of dermal major histocompatibility complex
(MHC) II APCs (Figure 1a and b). Donor skin was transplanted
onto the flanks of C57BL/6 (B6, H-2b) recipients and monitored
for signs of rejection (Figure 1c). Unlike syngeneic B6 grafts that
were maintained indefinitely, both Tgþ and wt FVB grafts were
rapidly rejected with similar kinetics.
We next examined male-female (H-Y) minor mismatch
grafts. Male donor skin from Tgþ and wt mice, which had
been backcrossed four generations onto the B6 background,
was transplanted onto littermate wt female recipients. As with
the fully allogeneic system, we observed brisk rejection of
both wt and Tgþ grafts with similar kinetics (Figure 1d).
These data clearly establish that LCs are not required for
efficient rejection of either MHC-mismatched or minor
histocompatibility antigen-mismatched skin allografts.
LCs are required for graft acceptance across an H-Y barrier
Because we had previously found that CHS is augmented in
Langerin-DTA mice, indicating that LCs participate in the
regulation of cutaneous immune responses, we were some-
what surprised that LC-deficient skin was not rejected more
rapidly than LC-replete skin. The rapid tempo of rejection in
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Figure 1. LCs are required for skin graft acceptance, but not rejection.
Partial thickness grafts from FVB Tgþ (a) or control (b) mice were stained with
for MHC II and counterstained with hematoxylin. Original magnification
200. (c) Grafts harvested from wt (solid line) and Tgþ (broken line) FVB (H-2q)
mice and grafted onto fully mismatched B6 (H-2b) mice. Both Tgþ and wt
grafts were rejected with similar kinetics. Control syngeneic B6 grafts (thin
line) were accepted indefinitely (4100 days). (d) Skin grafts harvested from wt
or Tgþ B6 males and transplanted onto B6 littermate females were rejected
with similar kinetics. Control B6 female skin was accepted indefinitely. (e) Wt
or Tgþ FVB male skin was placed on FVB littermate females. Tgþ grafts
lacking LCs were rejected much more frequently than wt skin (Po0.001).
Female Tgþ skin placed on littermate wt females was accepted indefinitely.
(f) Wt or Tgþ FVB male skin was placed on Tgþ FVB littermate females. Tgþ
grafts lacking LCs were rejected much more frequently than wt skin
(Po0.001). Control female wt skin placed on littermate wt females was
accepted indefinitely.
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both the FVB-B6 and B6 H-Y models raised the possibility
that detection of any regulatory effect of LCs could have been
obscured. Significant variability in the rejection response to
H-Y antigen between different strains of mice is well
documented and is thought to result from different T-cell
responses to the MHC–peptide complexes generated in
varying MHC haplotypes (Simpson et al., 1997). B6 mice
reject H-Y disparate grafts, whereas other non-H-2b strains,
such as C3H (H-2k) mice, do not.
We therefore next examined male-female (H-Y) minor
mismatch grafts on the FVB (H-2q) background. Male donor
skin from FVB Tgþ and wt mice was transplanted onto FVB wt
females. On the FVB background, we found indefinite (4100
days) graft survival of wt male skin when it was transplanted
onto wt female mice in 10/11 instances (Figure 1e). The
absence of LCs, however, led to the rejection of Tgþ grafts
over the course of 18–40 days in all but a single animal
(Figure 1e). As Tgþ grafts express DTA, it is conceivable that
the grafts could be rejected on the basis of recognition of the
toxin and not H-Y. In addition, the gene CLEC4F, a poorly
studied lectin expressed by Kupffer cells, is located adjacent to
the gene for Langerin on the BAC (Hoyle and Hill, 1988).
Although it is not thought to be expressed in the skin, CLEC4F
could also serve as a rejection antigen. To control for this
possibility, we transplanted female Tgþ grafts onto wt female
recipients (Figure 1e, thin line). The skin from female Tgþ mice
expresses DTA and other putative antigens encoded by the
BAC but not male-specific antigens. These grafts were
maintained indefinitely, demonstrating that expression of
antigens other than H-Y are not sufficient to mediate rejection.
We also transplanted male grafts onto Tgþ female recipients.
Tgþ recipients contain the BAC DNA from birth and are
tolerant to any potential rejection antigens that might be
encoded by the BAC. Just as with wt recipients, Tgþ male grafts
were rapidly rejected, whereas wt male grafts were maintained
(450 days) (Figure 1f). Thus, rejection of male grafts that lack
LC is based solely on recognition of male-specific antigens.
Grafts from wt male donors maintained graft size and dense
hair growth. In contrast, Tgþ grafts that were rejected deve-
loped hair loss and a greater than 90% reduction in graft
size. This is reflected in histology obtained on day 40 after
transplantation. Microscopic remnants of the rejection response
are evident in Tgþ grafts histologically as severely acanthotic
tissue that lacks hair follicles and has a CD8-dominant
mononuclear cell infiltrate (Figure 2). In contrast, grafted Tg
skin shows intact graft tissue with a mildly acanthotic epidermis
and the presence of hair follicles. As in Tgþ donor grafts, there
is also a CD8-dominant mononuclear cell infiltrate.
Investigation of LC function in graft acceptance
We have previously demonstrated that the absence of LCs
leads to increased priming when mice are sensitized with a
cutaneously applied hapten (Kaplan et al., 2005). Thus, we
next examined whether alterations in T-cell responses could
explain the enhanced rejection of Tgþ grafts. Responses were
examined 14 days after transplantation when evidence
of graft rejection first becomes evident. When we examined
the percentage of cytokine-producing CD4þ T cells in
skin-draining lymph nodes from mice transplanted with Tgþ
or wt grafts, we observed little production of IFN-g or IL-4 but
did observe a nonsignificant increase in IL-2-producing cells
in mice transplanted with Tgþ skin (Figure 3a). There was no
difference in IFN-g-producing CD8þ T cells between Tg and
Tgþ , but, as with CD4þ T cells, there was a trend toward an
increase in IL-2-producing cells in Tgþ recipients (Figure 3b).
Similar results were obtained when comparing the total
number of cytokine-producing cells (data not shown). We
did not also observe a significant difference in the total
numbers or percentages of activated CD4þ or CD8þ T cells in
Wt donor Tg+ donor
H&E
CD4
CD8
Figure 2. CD8þ cells infiltrate both wt and Tgþ FVB H-Y grafts. Graft tissue
was harvested from FVB females 40 days after grafting with male wt (left
panels) or Tgþ (right panels) skin. Sequential transverse sections were stained
with H&E (hematoxylin and eosin) (top panels), anti-CD4 (middle panels),
or anti-CD8 (bottom panels). Grafts from three mice in each group were
examined and representative sections are shown. Original magnification  100.
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lymph node or spleen based on the levels of CD44 and
CD62L expression (data not shown).
The development of regulatory T cells (Treg) has also been
shown to potentiate the long-term acceptance of allografts in
mouse models (Qin et al., 1993; Graca et al., 2000). We
therefore evaluated whether the absence of LCs affected Treg
generation in graft recipients. We quantified the percentage
of CD4þCD25þFoxp3þ in mice grafted with Tgþ and wt
skin (Figure 3c) and found equal percentage and numbers of
Tregs in both groups. Thus, we found no evidence that the
absence of LCs induced obvious differences in T-cell cytokine
production, activation state, or induction of Tregs that would
account for the dramatic differences in rejection responses.
However, these conclusions are tempered by the lack of an
antigen-specific marker in this H-2q system, and it remains
possible that there are effects on antigen-specific T cells that
were undetectable in analyses of bulk T cells.
Skin graft rejection, like CHS, is a classic assay of the
cutaneous immune response. The fact that grafts lacking
epidermal LCs are efficiently rejected demonstrates now in
two distinct in vivo systems that LCs are not required for skin
immune responses. Moreover, we observed that minor
mismatched skin grafts (FVB, H-Y) are not normally rejected
on the FVB background but are efficiently rejected if the
donor skin lacks LCs.
The vigorous rejection response elicited by allogeneic skin
has been attributed to the high density of APCs in this tissue
(He et al., 2004). The ability of LCs to migrate from
transplanted skin and their ability to stimulate host T cells
in vitro were part of the seminal studies that suggested the
importance of donor APC-host T-cell interaction in transplant
organ rejection (Larsen et al., 1990). We have clearly
demonstrated that donor-derived LCs present in the skin graft
tissue are not required for rejection. Skin contains numerous
resident APCs other than LCs in the dermis, such as dermal
DCs and macrophages (Romani et al., 2003; Larregina and
Falo, 2005). In addition, monocytes and monocytic DCs are
known to migrate into sites of inflammation (Le Borgne et al.,
2006; Leon et al., 2007). Although little is known regarding
the specific expression of male-associated antigens by
particular DC subsets, male-specific genes encoded on the
Y chromosome are expressed in all cell types. Thus, graft
resident DCs, other than LCs that present endogenous
antigens and/or host-derived DCs that present acquired
antigens, are clearly sufficient for graft rejection.
The requirement of LCs for graft acceptance in at least
certain instances further extends the concept that an
important function of LCs is regulating cutaneous immune
responses, consistent with our prior observation that LCs
regulate CHS responses. There is considerable evidence that
DCs participate in regulation of immune responses through both
the presentation of antigen by DCs in an immature state and by
DCs with regulatory properties (Steinman et al., 2003). It is
interesting to note that LCs retain their regulatory capacity
despite the surgically induced trauma of transplantation and
suggest that they may have an intrinsic regulatory capacity.
Indeed, another DC subset, plasmacytoid DCs, has been
recently shown to generate regulatory effects in allografted
mice treated with CD40L blockade (Ochando et al., 2006).
Bone marrow-derived and epithelial DCs conditioned with
factors, such as human thymic stromal lymphopoietin, IL-10,
and tissue growth factor-b, have been shown to promote
tolerance to presented antigens (Rimoldi et al., 2005; Svensson
and Kaye, 2006). Keratinocytes are a major source of both
human thymic stromal lymphopoietin and tissue growth factor-
b, which raises the possibility that LCs may be acting similarly
(Soumelis et al., 2002; Li et al., 2006).
As H-Y graft rejection is known to involve the generation
of CD4 helper and CD8 effector cells, we anticipated finding
T-cell differences in Tgþ and Tg graft recipients. Our
inability to detect any significant differences in T cells in mice
that reject or accept their graft could arise from a number of
factors. Changes in T-cell phenotype or activation state could
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Figure 3. No differences in T-cell phenotype in Wt and Tgþ FVB H-Y graft
recipients. Cells were harvested from skin-draining lymph nodes of FVB
female 14 days after grafting with male wt (circle) and Tgþ (triangle) skin.
Cells were stimulated ex vivo for 3 hours with PMA, and ionomycin in the
presence of IL-2. Cytokine expression was measured by intracellular flow
cytometry. There was no significant difference in the percentages of CD4þ
(a) or CD8þ (b) T cells expressing IFN-g, IL-2, or IL-4 in recipients grafted
with Tgþ or wt skin. (c) Day 14 after transplantation of skin grafts from
FVB wt or Tgþ males, the percentage of CD4þCD25þ Foxp3þ cells was
quantified by flow cytometry. There was no significant difference between
the groups.
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have been too subtle to be detected in the polyclonal
populations we examined or may be occurring within the
graft and not in the skin-draining lymph node or spleen.
Assays for anti-H-Y responses are relatively insensitive
without the use of tetramers or in vitro restimulation with
immunodominant peptides, neither of which have been
developed for the H-2q haplotype. Although there was no
difference in the number of Foxp3þ cells, LCs may promote
the development of Treg populations that do not express
Foxp3 (Shevach, 2006). Alternatively, there may be Foxp3þ
Tregs induced in an antigen-specific manner, but which are
too few to affect the total number of Foxp3þ cells. LCs may
also primarily affect other cell types, such as plasmacytoid
DCs or NK (natural killer) T cells, that have recently been
reported to exert tolerogenic effects in solid organ transplan-
tation (Oh et al., 2005; Ochando et al., 2006). Finally, LCs
present in the graft tissue could exert their regulatory effect
directly on graft-infiltrating effector cells. Although we
demonstrated that LCs exert their regulatory effect during
the priming and not elicitation phase during CHS to haptens,
their role in preventing skin graft rejection may be different.
Two groups have developed LC ablation models using
inducible expression of the diphtheria toxin receptor followed
by injection of toxin and observed that LCs are either not
required or are partially redundant for CHS responses (Bennett
et al., 2005; Kissenpfennig et al., 2005). Enhanced CHS
responses were not observed in either system. It is unclear
whether the absence of enhanced CHS responses in these mice
is due to the unanticipated elimination of Langerinþ dermal DC
and Langerinþ CD8þ DCs when LCs are ablated (Douillard
et al., 2005; Kissenpfennig et al., 2005; Bursch et al., 2007;
Ginhoux et al., 2007; Poulin et al., 2007) or reflects the
differences between the absence of LCs throughout ontogeny
(Langerin-DTA) and inducible LC ablation in adult mice.
The fact that FVB H-Y grafts lacking LCs are rejected when
transplanted onto normal animals indicates that the regula-
tory effect of LC is transferable with the skin. Any potential
systemic effects of the constitutive absence of LCs in
Langerin-DTA mice cannot be the cause for enhanced
responses. Thus, in addition to ruling out a role for LCs as a
requirement for skin rejection, our studies establish that the
regulatory role of LCs in Langerin-DTA mice is unlikely to
result from the absence of LCs during ontogeny.
MATERIALS AND METHODS
Mice
C57BL/6 (H-2b, hereafter B6) and FVB (H-2q) mice were purchased
from The Jackson Laboratory (Bar Harbor, ME) and Harlan
(Indianapolis, IN). The Langerin-DTA mice were described pre-
viously (Kaplan et al., 2005). They were derived and have been
maintained on a pure FVB background or backcrossed onto B6
(generation 4). Mice were housed in microisolator cages and fed
autoclaved food and acidified water. The Yale Institutional Animal
Care and Use Committee approved all mouse protocols.
Antibodies
Fluorochrome- or biotin-labeled antibodies to CD4 (RM4-5), CD8a
(53-6.7), IFN-g (XMG1.2), and IL-2 (JES6-5H4) were purchased from
BD Pharmingen (San Diego, CA). Anti-Foxp3 (FJK-16s) was
purchased from eBiosciences (San Diego, CA). Anti I-A/I-E (M5/
114.15.2) was purchased from BioLegend (San Diego, CA).
Skin grafting
Partial thickness skin transplantation was performed using abdom-
inal skin or tail skin (Figure 1f) from donor mice as described
previously (Obhrai et al., 2006). Grafts were monitored daily for the
first 4 weeks after transplantation and then every other day.
Rejection was defined as 490% graft loss.
Flow cytometry
To measure intracellular cytokine production, lymphocytes were
stimulated ex vivo with PMA and ionomycin for 3 hours in the
presence of IL-2 (10U per well) and monensin (Obhrai et al., 2006).
Cells were then washed, stained for surface markers, fixed,
permeabilized with 0.25% saponin, and incubated with anti-
cytokine antibody for 1 hour at room temperature. All samples were
analyzed on an LSR-II flow cytometer (BD Biosciences, Mountain
View, CA). The data were analyzed using FlowJo software (Tree Star
Inc., Ashland, OR).
Immunohistochemistry
Transverse tissue sections were obtained and processed as described
(Hannum et al., 2000). The sections were stained with biotinylated
anti-CD4, MHC II, or CD8 followed by streptavidin alkaline-
phosphatase (Invitrogen, Carlsbad, CA), and developed with Fast-
red as described (Hannum et al., 2000).
Statistical methods
The significance in skin graft rejection incidence was calculated by
Breslow–Gehan–Wilcoxon rank sum. Differences in the number of
cytokine-expressing cells were evaluated using Student’s t-test.
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